Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Distribution of Prostaglandin E1 in Lipid Emulsion in Relation to Release Rate from Lipid Particles
Tetsuo YAMAGUCHINoriko TANABEYumiko FUKUSHIMATeiko NASUHidefumi HAYASHI
Author information
JOURNAL FREE ACCESS

1994 Volume 42 Issue 3 Pages 646-650

Details
Abstract

The distribution style of prostaglandin E1 (PGE1) in injectable lipid emulsion (Lipo-PGE1) was analyzed using a three-phase model : an aqueous phase, an oil phase and an oil/water interface. A combination of the oil phase and the oil/water interface was obtained as the particle phase. Initial diffusion rates of PGE1 from lipid particls to the aqueous phase were determined by the dialysis method, and equilibrium concentrations were calculated by the diffusion rates using an equation derived from Fick's theory. Lipo-PGE1 enclosed in cellulose tubing was immersed in buffer solutions (pH 5.5, 7.4), then incubated at various constant temperatures. Each concentration of PGE1 in the aqueous phase was measured at appropriate intervals. By using these values, partition coefficients between the particle phase and the aqueous phase were calculated. It was found that a larger portion of PGE1 was distributed in the particle phase compared with the aqueous phase in Lipo-PGE1 at each temperature. Furthermore, actural partition coefficients between oil and aqueous phases were measured. From the results of two partition coefficients, the distribution ratio of PGE1 in Lipo-PGE1 was determined as : oil : oil/water interface : water=0.2 : 93.1 : 6.7, that is, 93% PGE1 was found to be distributed in lipid particles. On the other hand, by diluting PGE1 one hundred times with transfusion, the distribution ratio of PGE1 in lipid particles decreased as the pH of the transfusion increased. The ratios after 2 h were 74% and 47% for pH 5.5 and 7.4, respectively.In conclusion, a large portion of PGE1 was found to be distributed in the particle phase when Lipo-PGE1 was diluted with transfusion. Since most PGE1 exists in an oil/water interface, it is considered that it has a strong affinity for phospholipids. Thus, this affinity may contribute to the remarkable increase in activity in clinical treatment.

Content from these authors
© The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top